By proceeding, you agree to our Terms of Use and Privacy Policy.
Katherine Block has been working as a Director, Biomarker Sciences for Sangamo Therapeutics, Inc
Talks About #Biomarker
Preferred Locations #NorthAmerica
The 3rd Annual Gene Therapy Immunogenicity Summit is industry’s definitive forum enabling you to better modulate, measure and predict the immune response to your gene therapy candidate.